Gunze Medical and HistoSonics Enter into Exclusive Distributor Agreement in Japan for Noninvasive Platform and Proprietary Sonic Beam Therapy Using Histotripsy Technology
OSAKA, Japan — Gunze Limited (Headquarters: Osaka, Japan; President: Toshiyasu Saguchi) [TOKYO:3002] is pleased to announce that its wholly owned subsidiary, Gunze Medical Limited (Headquarters: Osaka, Japan; President: Shojiro Matsuda) and HistoSonics, Inc.
(Financial Post, 2025-10-08T04:02:16Z)